Merck & Co.’s COVID-19 pill gained a key recommendation from advisers to U.S. regulators, increasing the likelihood that the treatment for high-risk patients will be cleared for use in the…

Read more »

The post Merck’s COVID-19 Pill Gets Key Backing From FDA Advisory Panel appeared first on Hamodia.

In related news:

  1. ‘Where Are the Patients?’ People Are Avoiding Doctors, Hospitals Because of Coronavirus Worries
  2. Moderna on Track for Large COVID-19 Vaccine Test in July
  3. Dr. Anthony Fauci Skeptical of Call to Stop Saving COVID-19 Vaccines for Second Doses
  4. FDA to Scrutinize Vaccine Design Behind COVID-19 Shots Linked to Blood Clots
  5. Pfizer Asks U.S. Officials to OK Promising COVID-19 Pill